Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Selectivity interaction (Enzymatic assay) EUB0000685a PIK3C3
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Selectivity interaction (Enzymatic assay) EUB0000685a PIK3C2B
Affinity Biochemical interaction (Enzymatic fluorescence polarization assay) EUB0000685a PIK3CG
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Affinity Biochemical interaction (Enzymatic fluorescence polarization assay) EUB0000685a PIK3CD
Affinity Biochemical interaction (Enzymatic fluorescence polarization assay) EUB0000685a PIK3CB
Affinity Biochemical interaction (Enzymatic fluorescence polarization assay) EUB0000685a PIK3CA
Affinity Phenotypic Cellular interaction (MesoScale Discovery assay (AKT phoshorylation in MCF 7 cells)) EUB0000685a PIK3CG
Affinity Phenotypic Cellular interaction (MesoScale Discovery assay (AKT phoshorylation in MCF 7 cells)) EUB0000685a PIK3CD
Affinity Phenotypic Cellular interaction (MesoScale Discovery assay (AKT phoshorylation in MCF 7 cells)) EUB0000685a PIK3CB
Affinity Phenotypic Cellular interaction (MesoScale Discovery assay (AKT phoshorylation in MCF 7 cells)) EUB0000685a PIK3CA
Inhibition of PI3Kdelta in human B-cells assessed as reduction in CD69 expression preincubated for 1 hr followed by IgM stimulation for 18 hrs by flow cytometry analysis
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of PI3Kalpha H1047R mutant in human HCC1954 cells assessed as reduction in PRAS40 phosphorylation after 24 hrs by electrochemiluminescent assay
Assay data:15 Active, 13 Activity ≤ 1 µM, 17 Tested
Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS as substrate in presence of ATP measured after 120 mins by ADP-Glo assay
Assay data:36 Active, 27 Activity ≤ 1 nM, 36 Activity ≤ 1 µM, 36 Tested
Biochemical Inhibition Assay from US Patent US10851091: "Benzoxazepin oxazolidinone compounds and methods of use"
Assay data:21 Active, 17 Activity ≤ 1 nM, 21 Activity ≤ 1 µM, 21 Tested
p110alpha (Alpha) PI3K Binding Assay from US Patent US10112932: "Benzoxazepin oxazolidinone compounds and methods of use"
Assay data:20 Active, 17 Activity ≤ 1 nM, 20 Activity ≤ 1 µM, 20 Tested
Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an RCH-ACV wild type WT cells (2C)
Assay data:2970 Active, 9 Activity ≤ 1 nM, 1016 Activity ≤ 1 µM, 10037 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an isogenic RCH-ACV NSD2 p.E1099K mutant (9B)
Assay data:2826 Active, 4 Activity ≤ 1 nM, 946 Activity ≤ 1 µM, 10037 Tested
Inhibition of PI3K delta (unknown origin)
Assay data:2 Active, 2 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of PI3K alpha (unknown origin)
qHTS assay to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: Counter screen cell viability and HiBit confirmation
Assay data:347 Active, 1 Activity ≤ 1 nM, 215 Activity ≤ 1 µM, 650 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on